Javascript must be enabled to continue!
Intranodal benign thyroid tissue: Significance of HBME‐1 in differentiation from metastatic papillary thyroid carcinoma
View through CrossRef
The aim of this study was to determine the significance of HBME‐1 immunostaining in the differentiation between intranodal benign thyroid tissue and metastatic papillary thyroid carcinoma in the lymph node. Immunohistochemically we examined normal‐appearing intranodal thyroid tissue in four patients who did not show evidence of papillary carcinoma histologically or clinically. We also examined follicular‐pattern‐predominant papillary carcinoma with metastatic foci in the lymph nodes. Normal‐appearing intranodal thyroid tissue and normal thyroid showed no immunopositivity for HBME‐1. In contrast, all papillary carcinomas in both the lymph nodes and thyroid demonstrated strong positivity for HBME‐1. HBME‐1 was predominantly positive for the luminal surface of the tumor cells. The immunopositivity of the cuboidal and low columnar carcinoma cells was more intensive than that of the flat‐shaped cells in the lymph nodes and thyroid. The results probably indicate that HBME‐1 immunostaining is helpful in distinguishing between intranodal benign thyroid tissue and metastatic papillary carcinoma in lymph nodes. We emphasize that the HBME‐1 reactivity should be evaluated in connection with the histological findings, and that positive and negative controls stained in parallel are necessary.
Title: Intranodal benign thyroid tissue: Significance of HBME‐1 in differentiation from metastatic papillary thyroid carcinoma
Description:
The aim of this study was to determine the significance of HBME‐1 immunostaining in the differentiation between intranodal benign thyroid tissue and metastatic papillary thyroid carcinoma in the lymph node.
Immunohistochemically we examined normal‐appearing intranodal thyroid tissue in four patients who did not show evidence of papillary carcinoma histologically or clinically.
We also examined follicular‐pattern‐predominant papillary carcinoma with metastatic foci in the lymph nodes.
Normal‐appearing intranodal thyroid tissue and normal thyroid showed no immunopositivity for HBME‐1.
In contrast, all papillary carcinomas in both the lymph nodes and thyroid demonstrated strong positivity for HBME‐1.
HBME‐1 was predominantly positive for the luminal surface of the tumor cells.
The immunopositivity of the cuboidal and low columnar carcinoma cells was more intensive than that of the flat‐shaped cells in the lymph nodes and thyroid.
The results probably indicate that HBME‐1 immunostaining is helpful in distinguishing between intranodal benign thyroid tissue and metastatic papillary carcinoma in lymph nodes.
We emphasize that the HBME‐1 reactivity should be evaluated in connection with the histological findings, and that positive and negative controls stained in parallel are necessary.
Related Results
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Clinicopathological Features of Indeterminate Thyroid Nodules: A Single-center Cross-sectional Study
Clinicopathological Features of Indeterminate Thyroid Nodules: A Single-center Cross-sectional Study
Abstract
Introduction
Due to indeterminate cytology, Bethesda III is the most controversial category within the Bethesda System for Reporting Thyroid Cytopathology. This study exam...
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Abstract
Introduction
Non-Hodgkin lymphoma (NHL) of the thyroid, a rare malignancy linked to autoimmune disorders, is poorly understood in terms of its pathogenesis and treatment o...
Relationship between serum NDRG3 and papillary thyroid carcinoma
Relationship between serum NDRG3 and papillary thyroid carcinoma
BackgroundIn recent years, papillary thyroid carcinoma is considered to be one of the fastest increaseing cancer. NDRG family member 3 (NDRG3) has been proposed as a molecular mark...
Kikuchi-Fujimoto Disease Coexistent with Papillary Thyroid Carcinoma: A Report of Two Cases
Kikuchi-Fujimoto Disease Coexistent with Papillary Thyroid Carcinoma: A Report of Two Cases
Abstract
Introduction
Kikuchi-Fujimoto Disease (KFD), characterized by histiocytic necrotizing lymphadenitis, is a rare condition of unknown etiology. Diagnosis is dependent on lym...
SAT567 Collision Tumor Of The Thyroid With Papillary Thyroid Carcinoma And Metastatic Renal Clear Cell Carcinoma With Concomitant Parathyroid Adenoma
SAT567 Collision Tumor Of The Thyroid With Papillary Thyroid Carcinoma And Metastatic Renal Clear Cell Carcinoma With Concomitant Parathyroid Adenoma
Abstract
Disclosure: C.M. Mirano: None. R.C. Mirasol: None.
INTRODUCTION Collision tumors of the thyroid are rare diseases that have two or more histo...
Carcinoma ex Pleomorphic Adenoma: A Case Series and Literature Review
Carcinoma ex Pleomorphic Adenoma: A Case Series and Literature Review
Abstract
Introduction
Carcinoma ex pleomorphic adenoma (CXPA) is a rare malignant salivary gland tumor that can lead to severe complications and carries a risk of distant metastasi...
Molecular prognostication of thyroid tumors : with special focus on TERT
Molecular prognostication of thyroid tumors : with special focus on TERT
<p dir="ltr">Thyroid carcinoma is the most common endocrine malignancy, with its incidence steadily increasing worldwide. These tumors can be challenging to diagnose, and tre...

